A thousand new regulators
FDA will add 1,163 new employees to its staff by the end of the fiscal year, according to the agency. One thousand and five already are on board and 158 are due to report by Sept. 28. Another 160 candidates have accepted offers but are still undergoing clearance and related security processes, FDA says. The new hires, the result of a staffing initiative launched in the spring, will increase agency personnel to authorized levels (1"The Pink Sheet," May 5, 2008, p. 7). More than 850 of the new staff are in scientific or medical professions
You may also be interested in...
As Congress debates increased funding and other steps to improve FDA oversight of imported drugs, the agency plans to hire 1,317 people in the next six months to bring staff numbers up to their full authorized levels
The US FDA labelled the progress of Bayer’s 522 postmarket study of its Essure birth control device, which was pulled off the market in 2018, as “inadequate” due to significant numbers of women dropping out.
Plan for rolling submission means US FDA filing of GIP/GLP1 agonist in obesity could be complete by April 2023, setting up possibility of late 2023 approval.